NCT06527885

Lurasidone Non-Interventional Study in Schizophrenia Patients

Treatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 61 (actual)
• Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A · Industry
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The study is a multicentric, national, non-interventional, prospective, single arm study. The main goal of this study is to gather information about the effects, in a real-life setting, of lurasidone treatment on patient's reported outcomes, in terms of patient's treatment satisfaction, Quality of Life and functioning changes after 6 weeks from lurasidone treatment initiation in schizophrenia patients naïve to lurasidone.

Detailed description

Important aim of the study is to investigate, aspects related to effectiveness, safety and tolerability at 3 months' lurasidone treatment in a routine practice in Italian clinical settings. Only patients with primary diagnosis of schizophrenia who are prescribed lurasidone was evaluated for inclusion in the study.

Conditions

• Schizophrenia

Interventions

Type	Name	Description
DRUG	Lurasidone	Patients treated with Lurasidone in according to routine clinical practice, in Italy

Timeline

• Start date: 2022-10-21
• Primary completion: 2023-09-12
• Completion: 2023-09-12
• First posted: 2024-07-30
• Last updated: 2024-08-01

Locations

3 sites across 1 country: Italy